Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal

Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is developing an oral treatment for leukemia.

Previous Article

Days After Trump Delays Xi Summit, Chinese Carrier Unveils 101-Jet Airbus Deal

Next Article

KB Home says the war is already hurting home sales as it cuts guidance

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

− 3 = 5
Powered by MathCaptcha

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨